Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluating the Renoprotective Effect of Paracetamol in Paediatric Severe Malaria: a Randomised Controlled Trial

NCT04251351 is registered in ClinicalTrials.gov with University of British Columbia as lead sponsor.

NCT NCT04251351
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04251351 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluating the Renoprotective Effect of Paracetamol in Paediatric Severe Malaria: a Randomised Controlled Trial
Lead sponsor
University of British Columbia
Phase
Phase 3
Overall status
Unknown status
Start date
December 13, 2021
Completion date
November 1, 2025
Enrollment
460 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, malaria,falciparum, paracetamol, severe malaria